Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
89bio (ETNB)
NASDAQ:ETNB
Holding ETNB?
Track your performance easily
ETNB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.43 - $16.63
Previous Close$7.94
Volume4.50M
Average Volume (3M)936.78K
Market Cap
$826.60M
Enterprise Value$440.40M
Total Cash (Recent Filing)$423.77M
Total Debt (Recent Filing)$37.57M
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Mar 19, 2025EPS Estimate
-$0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.91
Shares Outstanding106,126,338
10 Day Avg. Volume1,288,289
30 Day Avg. Volume936,779
Standard Deviation0.24
R-Squared0.05
Alpha-0.00245
Financial Highlights & Ratios
Price to Book (P/B)2.23
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.59
Forecast
1Y Price Target
$27.00Price Target Upside240.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
89bio News
PremiumCompany Announcements
89bio Strengthens Leadership Retention with New RSUs
PremiumCompany Announcements
89Bio Inc. Reports Q3 2024 Financial Results
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ETNB FAQ
What was 89bio’s price range in the past 12 months?
89bio lowest stock price was $6.43 and its highest was $16.63 in the past 12 months.
What is 89bio’s market cap?
Currently, no data Available
When is 89bio’s upcoming earnings report date?
89bio’s upcoming earnings report date is Mar 19, 2025 which is in 88 days.
How were 89bio’s earnings last quarter?
89bio released its earnings results on Nov 07, 2024. The company reported -$1.39 earnings per share for the quarter, missing the consensus estimate of -$0.624 by -$0.766.
Is 89bio overvalued?
According to Wall Street analysts 89bio’s price is currently Undervalued.
Does 89bio pay dividends?
89bio does not currently pay dividends.
What is 89bio’s EPS estimate?
89bio’s EPS estimate is -$0.76.
How many shares outstanding does 89bio have?
89bio has 117,582,220 shares outstanding.
What happened to 89bio’s price movement after its last earnings report?
89bio reported an EPS of -$1.39 in its last earnings report, missing expectations of -$0.624. Following the earnings report the stock price went up 4.92%.
Which hedge fund is a major shareholder of 89bio?
Among the largest hedge funds holding 89bio’s share is RA Capital Management. It holds 89bio’s shares valued at 105M.
---
89bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.00 (240.05% Upside)
$27.00 (240.05% Upside)
Blogger Sentiment
Bullish
ETNB Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 53.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $202.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.8%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.38%
12-Months-Change
Fundamentals
Return on Equity
-73.31%
Trailing 12-Months
Asset Growth
-0.39%
Trailing 12-Months
Company Description
89bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
---
ETNB Stock 12 Month Forecast
Average Price Target
$27.00
▲(240.05% Upside)
Technical Analysis
Terns Pharmaceuticals
―
Akero Therapeutics
―
Viking Therapeutics
―
EyePoint Pharmaceuticals
―
Best Analysts Covering ETNB
1 Year
1 Year Success Rate
7/17 ratings generated profit
1 Year Average Return
+78.27%
reiterated a buy rating 7 months ago
Copying Justin Zelin's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of +78.27% per trade.
---